IBRX Investors: Contact Robbins LLP for Information Regarding the Pending Lead Plaintiff Deadline in the ImmunityBio, Inc. Class Action
August 09, 2023 15:07 ET
|
Robbins LLP
SAN DIEGO, Aug. 09, 2023 (GLOBE NEWSWIRE) -- Robbins LLP reminds investors that a shareholder filed a class action on behalf of all persons and entities that purchased or otherwise acquired...
IBRX Stock News: Contact Robbins LLP for Information Regarding ImmunityBio, Inc. Class Action
July 18, 2023 18:31 ET
|
Robbins LLP
SAN DIEGO, July 18, 2023 (GLOBE NEWSWIRE) -- Robbins LLP reminds investors that a shareholder filed a class action on behalf of all persons and entities that purchased or otherwise acquired...
ImmunityBio, Inc. (IBRX) Investor Alert: Robbins LLP Reminds Investors of Lead Plaintiff Deadline in ImmunityBio, Inc. Class Action
July 13, 2023 17:40 ET
|
Robbins LLP
SAN DIEGO, July 13, 2023 (GLOBE NEWSWIRE) -- Robbins LLP reminds investors that a shareholder filed a class action on behalf of all persons and entities that purchased or otherwise acquired...
ImmunityBio, Inc. (IBRX) Shareholder Notice: Robbins LLP Reminds Investors of Class Action Against ImmunityBio, Inc.
July 05, 2023 12:19 ET
|
Robbins LLP
SAN DIEGO, July 05, 2023 (GLOBE NEWSWIRE) -- Robbins LLP reminds investors that a shareholder filed a class action on behalf of all persons and entities that purchased or otherwise acquired...